ImmunoGen: Shares Take Flight On Ovarian Cancer Survival Data – What Happens Next?

Investment Overview ImmunoGen (NASDAQ:IMGN) – an under the radar, Waltham, Massachusetts based biotech founded in 1981 sent its shareholders into …

Read more